The Effectiveness of Idazoxan in Treating TRD
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2006
CompletedFirst Posted
Study publicly available on registry
February 22, 2006
CompletedJanuary 29, 2008
January 1, 2008
February 19, 2006
January 28, 2008
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- MDD patients
- Did not respond to at least one treatment of 4-6 weeks of SSRI in adequate dose
- In or out patients
You may not qualify if:
- Psychotic symptoms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chaim Sheba Medical Center
Ramat Gan, 52621, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Zohar, MD
Sheba Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
February 19, 2006
First Posted
February 22, 2006
Last Updated
January 29, 2008
Record last verified: 2008-01